Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JNJ
JNJ
Johnson & Johnson: Third Time’s Not the Charm for Expanded Xarelto Approval
Wall St Cheat Sheet
Mon, 01/20/14 - 11:11 am
JNJ
Xarelto
bloodthinners
FDA
J&J Continues ‘Strategic Pruning’ With This Divestiture
Wall St Cheat Sheet
Fri, 01/17/14 - 08:40 am
JNJ
diagnostics
Ortho Clinical Diagnostics
Carlyle
FDA advisory panel rejects J&J drug for acute coronary syndrome
Reuters
Thu, 01/16/14 - 04:54 pm
JNJ
acute coronary syndrome
Xarelto
advisory panels
FDA
Key Pharmaceutical Stocks Ready to Deliver Earnings Beats
Yahoo/Zacks.com
Thu, 01/16/14 - 11:44 am
earnings
Forest Labs
JNJ
Ironwood
The Carlyle Group Agrees to Acquire Johnson & Johnson’s Ortho-Clinical Diagnostics for $4.15 Billion
Marketwatch
Thu, 01/16/14 - 08:38 am
JNJ
Carlyle
Ortho Clinical Diagnostics
diagnostics
M&A
J&J Said to Agree to Sell Ortho Unit to Carlyle for $4 Billion
Bloomberg
Wed, 01/15/14 - 05:27 pm
JNJ
M&A
diagnostics
Ortho Clinical Diagnostics
Carlyle
FDA staff cautious about J&J's latest Xarelto application
Yahoo/Reuters
Tue, 01/14/14 - 09:26 am
FDA
JNJ
Xarelto
China pulls J&J trademark on OneTouch diabetes products
Fierce Pharma
Fri, 01/10/14 - 08:36 am
diabetes
China
JNJ
OneTouch
trademark
M&A Boom Seen in 2014 as Drug Hunt Spurs Biotech Deals
Bloomberg
Fri, 01/10/14 - 08:25 am
M&A
biotech
generics
Merck
Bristol-Myers Squibb
General Electric
Gilead Sciences
Thermo Fisher
Forest Labs
FDA
Acorda Therapeutics
Pfizer
JNJ
Roche
Pharmacyclics
J&J petitions FDA to require "similar" names for biosimilars, biologics
Yahoo/Reuters
Thu, 01/9/14 - 08:30 am
JNJ
FDA
biosimilars
Mylan
Novartis
Novadaq's Story Continues To Come Along
Seeking Alpha
Wed, 01/8/14 - 04:17 pm
Novadaq Technologies
devices
Covidien
JNJ
Intuitive Surgical
J&J Innovation launches a discovery pact with fledgling upstart Scholar Rock
Fierce Biotech
Wed, 01/8/14 - 09:39 am
Scholar Rock
JNJ Innovation
JNJ
autoimmune disease
Johnson & Johnson And Medivation: A Prostate Cancer Marketshare
Seeking Alpha
Tue, 01/7/14 - 12:51 pm
JNJ
Medivation
prostatce cancer
Astellas
Dendreon
Sanofi
Zytiga
Xtandi
Provenge
Pharmacyclics Shares Rise on Positive Leukemia Trial
Bloomberg
Tue, 01/7/14 - 11:49 am
Pharmacyclics
JNJ
Imbruvica
chronic lymphocytic leukemia
Pluristem's Positive Data Could Open Massive Muscle Injury Market
Seeking Alpha
Tue, 01/7/14 - 09:24 am
Pluristem Therapeutics
Stryker
JNJ
Zimmer
hip recall
PLX cell therapy
J&J's Synthes wins round in spat with ex-sales rep
Mass Device
Mon, 01/6/14 - 11:05 am
devices
JNJ
Synthes
J&J gambles $12.5M in rare Big Pharma bet on a stem cell therapy
Fierce Biotech
Mon, 01/6/14 - 09:49 am
JNJ
stem cells
Capricor
Tetraphase Pharmaceuticals: A Small Cap With Big Potential
Seeking Alpha
Sat, 01/4/14 - 04:14 pm
Tetraphase Pharmaceuticals
AstraZeneca
Cubist Pharmaceuticals
antiobiotics
Eravacycline
JNJ
Merck
Pfizer
Pharmacyclics: As Imbruvica Commercialization Begins, Sell-Off Creates Opportunity
Seeking Alpha
Fri, 01/3/14 - 11:56 am
Pharmacyclics
Imbruvica
JNJ
Roche
Celgene
Gilead Sciences
mantle cell lymphoma
Johnson & Johnson Seeking Higher Profits
Seeking Alpha
Thu, 01/2/14 - 11:18 am
JNJ
diagnostics
M&A
Carlyle
Pages
« first
‹ previous
…
106
107
108
109
110
111
112
113
114
…
next ›
last »